Take me to your bleeder: Recombinant factor VIIa —finding its way in cardiac surgery

In this issue of the Journal, Dr Zindovic and colleagues1 examined whether data from the Nordic Consortium for Acute Type A Aortic Dissection database indicated that use of recombinant factor VIIa (rFVIIa) was associated with mortality, stroke, or renal replacement therapy after acute type A aortic dissection (ATAAD) surgical repair. Bleeding in ATAAD repair is a concern to all surgeons performing such operations. Any adjunct to attenuate bleeding is appreciated, and in ATAAD, rFVIIa has been suggested to do so.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Editorial commentary Source Type: research